Rigel Pharma (RIGL) Misses Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $39.73 -2%
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
DIT, AMC, DPZ, More
Financial Fact:
General and administrative: 4.56M
Today's EPS Names:
DIT, AMC, DPZ, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q2 EPS of ($0.06), $0.04 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $36.84 million versus the consensus estimate of $33.7 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA expects Apple to top analyst expectations on July 30
- Domino's Q2 2026 earnings call rescheduled to 11 a.m. ET after webcast issues
- Eve Air Mobility pursues eVTOL certification in Brazil and Europe
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
